In the face of rising cost and scrutiny of clinical trials, modeling and simulation can test assumptions and make predictions that improve planning and decision-making across the full spectrum of therapeutic innovation. Drug safety and efficacy predictions are now used for clinical trial simulation (CTS) to inform individual trial design.

As more clinical teams better understand these techniques, the practice is rapidly growing in Regulatory, Scientific and Operational acceptance. Through CTS, Quintiles is diligently striving to improve the success rate of clinical trials.